Daly RJ - Search Results

1

FAK signaling in human cancer as a target for therapeutics.

Lee BY, Timpson P, Horvath LG, Daly RJ. Lee BY, et al. Among authors: daly rj. Pharmacol Ther. 2015 Feb;146:132-49. doi: 10.1016/j.pharmthera.2014.10.001. Epub 2014 Oct 12. Pharmacol Ther. 2015. PMID: 25316657 Review.

2

Distinction at the leading edge of the cell.

Timpson P, Daly RJ. Timpson P, et al. Among authors: daly rj. Bioessays. 2005 Apr;27(4):349-52. doi: 10.1002/bies.20213. Bioessays. 2005. PMID: 15770683

3

Cortactin overexpression inhibits ligand-induced down-regulation of the epidermal growth factor receptor.

Timpson P, Lynch DK, Schramek D, Walker F, Daly RJ. Timpson P, et al. Among authors: daly rj. Cancer Res. 2005 Apr 15;65(8):3273-80. doi: 10.1158/0008-5472.CAN-04-2118. Cancer Res. 2005. PMID: 15833860

4

Aberrant expression of cortactin in head and neck squamous cell carcinoma cells is associated with enhanced cell proliferation and resistance to the epidermal growth factor receptor inhibitor gefitinib.

Timpson P, Wilson AS, Lehrbach GM, Sutherland RL, Musgrove EA, Daly RJ. Timpson P, et al. Among authors: daly rj. Cancer Res. 2007 Oct 1;67(19):9304-14. doi: 10.1158/0008-5472.CAN-07-0798. Cancer Res. 2007. PMID: 17909038

5

Protein kinase Cdelta and calmodulin regulate epidermal growth factor receptor recycling from early endosomes through Arp2/3 complex and cortactin.

Lladó A, Timpson P, Vilà de Muga S, Moretó J, Pol A, Grewal T, Daly RJ, Enrich C, Tebar F. Lladó A, et al. Among authors: daly rj. Mol Biol Cell. 2008 Jan;19(1):17-29. doi: 10.1091/mbc.e07-05-0411. Epub 2007 Oct 24. Mol Biol Cell. 2008. PMID: 17959830 Free PMC article.

6

Annexin A6 inhibits Ras signalling in breast cancer cells.

Vilá de Muga S, Timpson P, Cubells L, Evans R, Hayes TE, Rentero C, Hegemann A, Reverter M, Leschner J, Pol A, Tebar F, Daly RJ, Enrich C, Grewal T. Vilá de Muga S, et al. Among authors: daly rj. Oncogene. 2009 Jan 22;28(3):363-77. doi: 10.1038/onc.2008.386. Epub 2008 Oct 13. Oncogene. 2009. PMID: 18850003

7

Phosphorylation-dependent binding of 14-3-3 terminates signalling by the Gab2 docking protein.

Brummer T, Larance M, Herrera Abreu MT, Lyons RJ, Timpson P, Emmerich CH, Fleuren ED, Lehrbach GM, Schramek D, Guilhaus M, James DE, Daly RJ. Brummer T, et al. Among authors: daly rj. EMBO J. 2008 Sep 3;27(17):2305-16. doi: 10.1038/emboj.2008.159. EMBO J. 2008. PMID: 19172738 Free PMC article.

8

Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.

Hochgräfe F, Zhang L, O'Toole SA, Browne BC, Pinese M, Porta Cubas A, Lehrbach GM, Croucher DR, Rickwood D, Boulghourjian A, Shearer R, Nair R, Swarbrick A, Faratian D, Mullen P, Harrison DJ, Biankin AV, Sutherland RL, Raftery MJ, Daly RJ. Hochgräfe F, et al. Among authors: daly rj. Cancer Res. 2010 Nov 15;70(22):9391-401. doi: 10.1158/0008-5472.CAN-10-0911. Epub 2010 Sep 21. Cancer Res. 2010. PMID: 20861192

9

Targeting the human kinome for cancer therapy: current perspectives.

Zhang L, Daly RJ. Zhang L, et al. Among authors: daly rj. Crit Rev Oncog. 2012;17(2):233-46. doi: 10.1615/critrevoncog.v17.i2.70. Crit Rev Oncog. 2012. PMID: 22471710 Review.

10

Involvement of Lyn and the atypical kinase SgK269/PEAK1 in a basal breast cancer signaling pathway.

Croucher DR, Hochgräfe F, Zhang L, Liu L, Lyons RJ, Rickwood D, Tactacan CM, Browne BC, Ali N, Chan H, Shearer R, Gallego-Ortega D, Saunders DN, Swarbrick A, Daly RJ. Croucher DR, et al. Among authors: daly rj. Cancer Res. 2013 Mar 15;73(6):1969-80. doi: 10.1158/0008-5472.CAN-12-1472. Epub 2013 Feb 1. Cancer Res. 2013. PMID: 23378338

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

214 results

Search Page